University of North Carolina at Chapel Hill researchers have developed a blood test that may be able to predict when a macular degeneration patient will begin to lose his or her sight, according to a WRAL report.
A rare stem cell in the blood, a progenitor, functions as a barometer for macular degeneration activity. The UNC test is able to measure the progress of the disease through the progenitor.
The UNC small pilot test will move forward to a multicenter trial.
More Articles on Ophthalmology:
10 Eye Specialists Earn National Awards for One-Page Proposals
C-Reactive Protein Again Linked to Macular Degeneration
Houston Ophthalmologists Named 'Best Doctors'
A rare stem cell in the blood, a progenitor, functions as a barometer for macular degeneration activity. The UNC test is able to measure the progress of the disease through the progenitor.
The UNC small pilot test will move forward to a multicenter trial.
More Articles on Ophthalmology:
10 Eye Specialists Earn National Awards for One-Page Proposals
C-Reactive Protein Again Linked to Macular Degeneration
Houston Ophthalmologists Named 'Best Doctors'